These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15149320)

  • 41. Effects of indomethacin on furosemide induced renal prostaglandin synthesis and action in man.
    Kim RB; McCauley FA; Wilson TW
    Clin Invest Med; 1986; 9(3):192-7. PubMed ID: 3530574
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids.
    Catella-Lawson F; McAdam B; Morrison BW; Kapoor S; Kujubu D; Antes L; Lasseter KC; Quan H; Gertz BJ; FitzGerald GA
    J Pharmacol Exp Ther; 1999 May; 289(2):735-41. PubMed ID: 10215647
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rofecoxib decreases renal injury in obese Zucker rats.
    Dey A; Maric C; Kaesemeyer WH; Zaharis CZ; Stewart J; Pollock JS; Imig JD
    Clin Sci (Lond); 2004 Dec; 107(6):561-70. PubMed ID: 15307815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sodium salicylate inhibits prostaglandin formation without affecting the induction of cyclooxygenase-2 by bacterial lipopolysaccharide in vivo.
    Giuliano F; Mitchell JA; Warner TD
    J Pharmacol Exp Ther; 2001 Dec; 299(3):894-900. PubMed ID: 11714873
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo.
    Dowd NP; Scully M; Adderley SR; Cunningham AJ; Fitzgerald DJ
    J Clin Invest; 2001 Aug; 108(4):585-90. PubMed ID: 11518732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Upregulation of macula densa cyclooxygenase-2 expression is not dependent on glomerular filtration.
    Schweda F; Kammerl M; Wagner C; Krämer BK; Kurtz A
    Am J Physiol Renal Physiol; 2004 Jul; 287(1):F95-101. PubMed ID: 15180925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
    Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
    J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of COX-2 prevents hypertension and proteinuria associated with a decrease of 8-iso-PGF2alpha formation in L-NAME-treated rats.
    Tomida T; Numaguchi Y; Nishimoto Y; Tsuzuki M; Hayashi Y; Imai H; Matsui H; Okumura K
    J Hypertens; 2003 Mar; 21(3):601-9. PubMed ID: 12640255
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiovascular and renal effects of cyclooxygenase inhibition in transgenic rats harboring mouse renin-2 gene (TGR[mREN2]27).
    Cheng ZJ; Finckenberg P; Louhelainen M; Merasto S; Tikkanen I; Vapaatalo H; Mervaala EM
    Eur J Pharmacol; 2003 Feb; 461(2-3):159-69. PubMed ID: 12586211
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antithrombin reduces ischemia/reperfusion-induced liver injury in rats by activation of cyclooxygenase-1.
    Harada N; Okajima K; Uchiba M; Kushimoto S; Isobe H
    Thromb Haemost; 2004 Sep; 92(3):550-8. PubMed ID: 15351851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide.
    Nüsing RM; Reinalter SC; Peters M; Kömhoff M; Seyberth HW
    Clin Pharmacol Ther; 2001 Oct; 70(4):384-90. PubMed ID: 11673754
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of COX-2-derived metabolites in regulation of the renal hemodynamic response to norepinephrine.
    Llinás MT; López R; Rodríguez F; Roig F; Salazar FJ
    Am J Physiol Renal Physiol; 2001 Nov; 281(5):F975-82. PubMed ID: 11592955
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
    Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
    J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclooxygenase 2 pathway mediates IL-1beta regulation of IL-1alpha, -1beta, and IL-6 mRNA levels in Leydig cell progenitors.
    Walch L; Morris PL
    Endocrinology; 2002 Sep; 143(9):3276-83. PubMed ID: 12193539
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute renal failure and hyperkalaemia associated with cyclooxygenase-2 inhibitors.
    Braden GL; O'Shea MH; Mulhern JG; Germain MJ
    Nephrol Dial Transplant; 2004 May; 19(5):1149-53. PubMed ID: 14993496
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interactions of the renin-angiotensin system and neuronal nitric oxide synthase in regulation of cyclooxygenase-2 in the macula densa.
    Harris RC; Cheng H; Wang J; Zhang M; McKanna JA
    Acta Physiol Scand; 2000 Jan; 168(1):47-51. PubMed ID: 10691779
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of microsomal prostaglandin E synthase 1 in the kidney.
    Francois H; Facemire C; Kumar A; Audoly L; Koller B; Coffman T
    J Am Soc Nephrol; 2007 May; 18(5):1466-75. PubMed ID: 17442791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular thrombotic events and COX-2 inhibitors: results in patients with osteoarthritis receiving rofecoxib.
    Bannwarth B; Ravaud P; Dougados M
    J Rheumatol; 2003 Feb; 30(2):421-2. PubMed ID: 12583353
    [No Abstract]   [Full Text] [Related]  

  • 60. Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis.
    Kato S; Ogawa Y; Kanatsu K; Okayama M; Watanabe T; Arakawa T; Takeuchi K
    J Pharmacol Exp Ther; 2002 Nov; 303(2):503-9. PubMed ID: 12388629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.